P1.01-95 Efficacy and Safety of Anlotinib in Combination with Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
2019 ◽
Vol 14
(10)
◽
pp. S398
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 14
(10)
◽
pp. S129
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 14
(10)
◽
pp. S439
◽
Keyword(s):
2017 ◽
Vol 12
(11)
◽
pp. S2085-S2086
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):